| abstract |
Provided is a pharmacological composition which employs Monascus sp. and a pharmaceutically efficacious natural material so as to simultaneously contain a statin compound, which constitutes a cholesterol biosynthesis inhibitor, together with a composite bioactive substance such as a compound of Coenzyme Q (Ubiquinone, CoQ10) which constitutes a substance which causes complications such as myalgia due to the long-term use of the statin. |